pCS2-MT GLI2 delta N Citations (10)
Originally described in: A previously unidentified amino-terminal domain regulates transcriptional activity of wild-type and disease-associated human GLI2.Roessler E, Ermilov AN, Grange DK, Wang A, Grachtchouk M, Dlugosz AA, Muenke M Hum Mol Genet. 2005 Aug 1. 14(15):2181-8. PubMed Journal
Articles Citing pCS2-MT GLI2 delta N
| Articles |
|---|
| Gli2 expression and human bladder transitional carcinoma cell invasiveness. Mechlin CW, Tanner MJ, Chen M, Buttyan R, Levin RM, Mian BM. J Urol. 2010 Jul;184(1):344-51. doi: 10.1016/j.juro.2010.03.007. Epub 2010 May 20. PubMed |
| Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition. Tang Y, Gholamin S, Schubert S, Willardson MI, Lee A, Bandopadhayay P, Bergthold G, Masoud S, Nguyen B, Vue N, Balansay B, Yu F, Oh S, Woo P, Chen S, Ponnuswami A, Monje M, Atwood SX, Whitson RJ, Mitra S, Cheshier SH, Qi J, Beroukhim R, Tang JY, Wechsler-Reya R, Oro AE, Link BA, Bradner JE, Cho YJ. Nat Med. 2014 Jul;20(7):732-40. doi: 10.1038/nm.3613. Epub 2014 Jun 29. PubMed |
| Lack of centrioles and primary cilia in STIL(-/-) mouse embryos. David A, Liu F, Tibelius A, Vulprecht J, Wald D, Rothermel U, Ohana R, Seitel A, Metzger J, Ashery-Padan R, Meinzer HP, Grone HJ, Izraeli S, Kramer A. Cell Cycle. 2014;13(18):2859-68. doi: 10.4161/15384101.2014.946830. PubMed |
| Survivin, a novel target of the Hedgehog/GLI signaling pathway in human tumor cells. Vlckova K, Ondrusova L, Vachtenheim J, Reda J, Dundr P, Zadinova M, Zakova P, Pouckova P. Cell Death Dis. 2016 Jan 14;7:e2048. doi: 10.1038/cddis.2015.389. PubMed |
| Novel Molecular Mechanism of Regulation of CD40 Ligand by the Transcription Factor GLI2. Han W, Jackson DA, Matissek SJ, Misurelli JA, Neil MS, Sklavanitis B, Amarsaikhan N, Elsawa SF. J Immunol. 2017 Jun 1;198(11):4481-4489. doi: 10.4049/jimmunol.1601490. Epub 2017 May 1. PubMed |
| Novel GLI2 mutations identified in patients with Combined Pituitary Hormone Deficiency (CPHD): Evidence for a pathogenic effect by functional characterization. Babu D, Fanelli A, Mellone S, Muniswamy R, Wasniewska M, Prodam F, Petri A, Bellone S, Salerno MC, Giordano M. Clin Endocrinol (Oxf). 2019 Mar;90(3):449-456. doi: 10.1111/cen.13914. Epub 2019 Jan 7. PubMed |
| Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer. Adams CR, Htwe HH, Marsh T, Wang AL, Montoya ML, Subbaraj L, Tward AD, Bardeesy N, Perera RM. Elife. 2019 May 28;8. pii: 45313. doi: 10.7554/eLife.45313. PubMed |
| Attenuation of hedgehog/GLI signaling by NT1721 extends survival in pancreatic cancer. Kowolik CM, Lin M, Xie J, Overman LE, Horne DA. J Exp Clin Cancer Res. 2019 Oct 28;38(1):431. doi: 10.1186/s13046-019-1445-z. PubMed |
| Saikosaponin B1 and Saikosaponin D inhibit tumor growth in medulloblastoma allograft mice via inhibiting the Hedgehog signaling pathway. Luo J, Wang J, Yang J, Huang W, Liu J, Tan W, Xin H. J Nat Med. 2022 Jun;76(3):584-593. doi: 10.1007/s11418-022-01603-8. Epub 2022 Feb 16. PubMed |
| The Hedgehog/GLI signaling pathway activates transcription of Slug (Snail2) in melanoma cells. Horak P, Kreisingerova K, Reda J, Ondrusova L, Balko J, Vachtenheim J Jr, Zakova P, Vachtenheim J. Oncol Rep. 2023 Apr;49(4):75. doi: 10.3892/or.2023.8512. Epub 2023 Mar 3. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.